The Summit Rally Reversal: Why China Tech Is a Sell Again
Context
Markets entered the week bracing for the first U.S.-China presidential summit in nine years. Expectations were deliberately lowered after months of tit-for-tat tariffs and export controls. By the time Air Force One touched down in Beijing, the bar was underground: anything short of a fistfight would be hailed as diplomacy. That is exactly what happened. Presidents Trump and Xi shook hands, toured Zhongnanhai and the Temple of Heaven, and emerged with platitudes. The U.S. Trade Representative offered a vague commitment that China would buy "double-digit billions" in American farm goods over three years. Beijing released no fact sheet. The result was a photo-op dressed as a thaw — and a classic "sell the news" setup for China equities.
What Happened
The summit ran May 14–15 in Beijing. According to Barron's, the meeting "reset relations with few concrete breakthroughs." Scott Kennedy of CSIS told reporters he expects a one-year extension of the existing tariff detente, plus a new "Board of Trade" mechanism for implementation. In other words, the status quo got a paint job. Xi warned Trump that mishandling Taiwan could trigger conflict — a slightly sharper version of Beijing's usual script. On the economic front, there was zero movement on China's industrial subsidies, state-owned enterprise dominance, or global trade imbalances. Kennedy called it a "grand bargain on China's terms," because Beijing conceded nothing on its red lines while securing relief from the three-digit tariff threats Trump had floated a year earlier.
Meanwhile, Alibaba Group (BABA) reported Q4 FY26 earnings that exposed the ugly reality beneath the summit's polished surface. Revenue came in at RMB 243.4 billion, but net income collapsed to roughly RMB 1.5 billion — a margin implosion driven by aggressive AI and cloud capex. The stock, which had rallied into the summit on hope, reversed hard and was last seen at $132.59, down roughly 6% on the session. The "China tech recovery" narrative was dead on arrival.
Why It Matters
Investors mistook the absence of new tariffs for progress. It is not. A one-year detente extension merely postpones the next escalation cycle to 2027, right when the U.S. presidential campaign heats up. Without structural reform in Beijing — or credible enforcement mechanisms in Washington — the underlying trajectory of decoupling is unchanged. The agricultural purchase pledges are recycled from the Phase One playbook, and we know how that ended.
More importantly, the summit did nothing to address the profitability squeeze hitting China's tech champions. BABA's quarter proves that the new growth mandate is AI infrastructure, and AI infrastructure is capital-intensive. Margins will stay compressed for years. If the market leader cannot earn money in a "thaw," the rest of the sector is in deeper trouble. The bullish case for KWEB and FXI rests on multiple expansion — but multiples cannot expand when earnings are deteriorating.
Second-Order Effects
The immediate aftermath is a capital-flight rebound. Foreign fund flows into Hong Kong and U.S.-listed ADRs had turned mildly positive ahead of the summit. Those inflows will reverse now that the event risk is gone and the outcome is hollow. Watch for the Hang Seng Tech Index to underperform the broader HSI as beta-heavy names bleed out.
Within the sector, capital will rotate from geopolitically exposed names toward structurally insulated ones. Pinduoduo (PDD) is the standout. Trading near $95.83, PDD is up slightly on the day because its Temu business model is global commerce arbitrage, not U.S.-China diplomacy. Its low debt, high free-cash-flow profile, and minimal exposure to Beijing's industrial-policy directives make it the only clean shirt in the dirty laundry. JD.com (JD), by contrast, remains tied to domestic consumption and logistics — both vulnerable to a slower Chinese economy and renewed trade friction. JD was last at $32.01, down 2.6%.
The China ETF complex is also flashing warning signs. KWEB is bleeding NAV while carrying a 7.4% headline yield — a classic yield trap if the underlying equities keep falling. FXI and MCHI are both trading near 52-week lows, and their heavy weightings in state-owned financials and consumer cyclicals make them poor vehicles for a "reopening" trade that never actually opened.
The Trade
The contrarian setup is short the China-tech optimism complex via options. If you can trade U.S. options:
- Buy KWEB June $27 puts or sell June $29/$30 bear call spreads. The ETF is trading in the mid-$28 range, and a retest of the 52-week low near $27.62 is likely as flows reverse.
- Short FXI outright or via put spreads. The fund's 35% weight in financial services makes it a leveraged play on any deterioration in credit conditions or property-sector contagion.
- Pair the shorts with a long in PDD ($95.83) as a relative-value hedge. PDD's Temu revenue is USD-denominated and largely outside the crosshairs of both Washington and Beijing.
For equity-only accounts, trim KWEB/FXI exposure and swap into PDD. For the more aggressive, a 1×2 put spread on BABA ($130/$125 June) captures the post-earnings drift lower without paying excessive volatility premium.
Risk Check
The obvious risk is policy surprise. If Washington and Beijing quietly negotiate a meaningful tariff reduction on nonstrategic consumer goods — as Kennedy's "Board of Trade" mechanism hints — FXI could snap back 5–7% in a week. That is a short-squeeze risk, not a fundamentals reversal.
BABA's AI bet could pay off in 2027 if its Qwen models capture enterprise share, reversing the margin narrative. And PDD is not bulletproof: the EU is sharpening its regulatory knives on Temu's supply-chain compliance, and any action there would hit the one clean shirt in the drawer.
Finally, remember that China equities trade on narrative velocity, not valuation. A single Trump tweet or Xi speech can reprice the complex overnight. Size positions for volatility, not certainty.